Skip to Content

Notice

The National Institutes of Health (NIH) Sexual & Gender Minority Research Listening Session

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institutes of Health, HHS.

ACTION:

Notice.

SUMMARY:

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) will be holding a listening session with the Sexual & Gender Minority (SGM) community. The primary objectives of the NIH's listening session are: (1) To hear from community stakeholders about what issues are on their minds with regard to SGM-related research and related activities at the NIH, and (2) to use these individual viewpoints to help inform the development of the NIH SGM Research FY 2021-2025 strategic plan. The goal is to hold a listening session every year, to provide different SGM focused organizations an opportunity to join a session in person.

DATES:

The listening session with the SGM community will be held on October 22, 2019 at 11:00 a.m. ET.

ADDRESSES:

The meeting will be held at the National Institutes of Health, Building 1, Wilson Hall, Bethesda, MD 20892 for invited participants; the meeting will be open to the public remotely at 1-877-951-0634, Passcode: 6617257#.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Karen Parker, Ph.D., MSW, Director, Sexual & Gender Minority Research Office (SGMRO), 6555 Rock Spring Drive, Rm 2SE31K, Bethesda, MD 20817, klparker@mail.nih.gov, 301-451-2055.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

“Sexual and gender minority” is an umbrella term that includes, but is not limited to, individuals who identify as lesbian, gay, bisexual, asexual, transgender, two-spirit, queer, and/or intersex. Individuals with same-sex or -gender attractions or behaviors and those with a difference in sex development are also included. These populations also encompass those who do not self-identify with one of these terms but whose sexual orientation, gender identity or expression, or reproductive development is characterized by non-binary constructs of sexual orientation, gender, and/or sex.

The Sexual and Gender Minority Research Office (SGMRO) coordinates sexual and gender minority (SGM)-related research and activities by working directly with the NIH Institutes, Centers, and Offices. The Office was officially established in September 2015 within the NIH Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) in the Office of the Director.

The SGMRO has the following research-related goals: (1) Expand the knowledge base of SGM health and well-being through NIH-supported research; (2) Remove barriers to planning, conducting, and reporting NIH-supported research about SGM health and well-being; (3) Strengthen the community of researchers and scholars who conduct research relevant to SGM health and well-being; and (4) Evaluate progress on advancing SGM research.

Listening Session Details

The listening session event will be a trans-NIH effort, with representation from several NIH Institutes, Centers, and Offices. The listening session will be open to the public to listen in; comments submitted via email will be accepted post-listening session. Comments, questions, or feedback can be shared with SGMRO@nih.gov. SGMRO will invite approximately 20 SGM focused organizations to attend the listening session in-person. Selection of the organizations will be based on the diversity of their missions and efforts.

Start Signature

Dated: August 27, 2019.

Lawrence A. Tabak,

Principal Deputy Director, National Institutes of Health.

End Signature End Supplemental Information

[FR Doc. 2019-19085 Filed 9-4-19; 8:45 am]

BILLING CODE 4140-01-P